Total synthesis of elansolids B1 and B2 by Wang, Liang-Liang & Kirschning, Andreas
1280
Total synthesis of elansolids B1 and B2
Liang-Liang Wang and Andreas Kirschning*
Full Research Paper Open Access
Address:
Institute of Organic Chemistry and Center of Biomolecular Drug
Research (BMWZ), Leibniz University Hannover, Schneiderberg 1b,
30167 Hannover, Germany
Email:
Andreas Kirschning* - andreas.kirschning@oci.uni-hannover.de
* Corresponding author
Keywords:
antibiotics; polyenes; polyketides; Stille reaction; Suzuki reaction; total
synthesis
Beilstein J. Org. Chem. 2017, 13, 1280–1287.
doi:10.3762/bjoc.13.124
Received: 03 April 2017
Accepted: 17 May 2017
Published: 28 June 2017
This article is part of the Thematic Series "Lipids: fatty acids and
derivatives, polyketides and isoprenoids".
Guest Editor: J. S. Dickschat
© 2017 Wang and Kirschning; licensee Beilstein-Institut.
License and terms: see end of document.
Abstract
The elansolids A1–A3, B1, and B2 are secondary metabolites formed by the gliding bacterium Chitinophaga sancti. They show
antibacterial activity against Gram-positive bacteria. A second generation total synthesis of the antibiotic elansolid B1 (2) and the
first synthesis of elansolid B2 (3) are reported. In contrast to previous work, the (Z,E,Z)-triene at C10–C15 was assembled by using
an optimized C–C cross-coupling sequence with a Suzuki cross-coupling reaction as key step.
Introduction
The elansolids are metabolites from the gliding bacterium
Chitinophaga sancti (formerly Flexibacter spec.) (Figure 1)
[1,2]. Elansolid A2 (1*), an atropisomer of elansolid A1 (1),
showed antibiotic activity against Gram-positive bacteria in the
range of 0.2 to 64 µg/mL and cytotoxicity against L929 mouse
fibroblast cells with an IC50 value of 12 µg/mL. Besides these
two macrocylic members also elansolids B1 (2) and B2 (3)
along with A3 (4) bearing the unusual p-quinone methide unit
were isolated from the fermentation broth. All elansolids belong
to the group of trans-polyketides type I [3-6].
For the first generation total synthesis of elansolid B1 (2) we
utilized an endo-selective intramolecular Diels–Alder (IMDA)
cycloaddition as key step to construct the tetrahydroindane unit
(Scheme 1) [7]. An enone, derived from allylic alcohol 8 served
as precursor to yield tetrahydroindane 9 with excellent diastere-
ocontrol at −25 °C. The major drawback of our first total syn-
thesis of elansolid B1 (2) was the installation of the side chain
at C1–C13. The synthesis relied on two consecutive Sono-
gashira–Hagihara cross-coupling reactions that provided the
ene–diyne system (C10–C15) 10 in good yield. However,
partial hydrogenation (only the zinc–copper couple worked)
furnished the desired (Z,E,Z)-triene 11 in only low yield (35%)
and overreduction was difficult to control. Practically, the
reduction was stopped when still substantial amounts of
monoreduced product (the alkyne at C10–C11 is reduced pref-
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Figure 1: Elansolids A1/A2, B1, B2 and A3 (1–4).
Scheme 1: IMDA to generate the tetrahydroindane unit of the elansolids by oxidation of benzyl ether 8 as precursor and construction of the (Z,E,Z)-
triene unit at C10–C15 (TPAP = tetra-n-propylammonium perruthenate(VII); PMB = p-methoxybenzyl; Bn = benzyl).
erentially) were present. Consequently, the hydrogenation
yielded a mixture of products, which in any case made the sepa-
ration and isolation a very challenging task.
As continuation of our synthetic investigations on the elan-
solids, we report an improved second generation approach for
generating the carbon chain C1–C13 [8] and for preparing elan-
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Scheme 2: Stille cross-coupling reaction and formation of eastern fragment 13.
solid B1 (2). Furthermore, we also describe the first synthesis of
elansolid B2 (3). The key for improvement was to abandon the
two Sonogashira reactions along with the syn-reductions of the
two alkynes. Instead, we planned to utilize the Suzuki–Miyaura
and the Stille reactions and two Z-configured vinyl iodides to
assemble the (Z,E,Z)-triene unit.
Results and Discussion
The improved synthesis utilizes the Suzuki–Miyaura cross-cou-
pling reaction to merge the western fragment derived from ke-
tone 9 with the newly designed eastern building block 13. This
fragment was obtained in very good yield from vinyl iodide 12
[9] by a Stille protocol using doubly functionalized alkene 14
which is suited for a sequential cross-coupling strategy
(Scheme 2). Under the catalytic conditions, we did not encoun-
ter isomerization of the alkene and diene configurations in vinyl
boronate 13.
The preparation of the newly modified western fragment started
from known IMDA product 9 [7], which was first reduced at
C-25 (Scheme 3). The two diastereoisomers could be separated
by chromatography and the stereochemical assignment of the
major isomer was based on X-ray crystallographic analysis [7].
Next, Tamao–Fleming oxidation [10] yielded phenol 15. The
alkyne was transformed into vinyl iodide 17 after O-acylation,
iodination of the terminal alkyne and finally diimide-mediated
syn-reduction [11].
Next, DDQ-mediated removal of the PMB protecting group
yielded vinyl iodide 18. The synthesis of both fragments 13 and
18 set the stage for the Suzuki–Miyaura coupling which deliv-
ered the desired (Z,E,Z)-configured triene 19. Again, we did not
encounter formation of stereoisomers in the triene unit. The
configuration of the triene was unequivocally assigned by anal-
ysis of coupling constants (J) and by measuring nuclear Over-
hauser effects (nOe). Finally, desilylation and global saponifica-
tion of all ester groups in the presence of isopropanol success-
fully yielded elansolid B1 (2). When isopropanol was
exchanged by methanol, elansolid B2 (3) was generated. Its for-
mation can be rationalized by formation of the intermediate
p-methide quinone which selectively trapped methanol, exclu-
sively yielding the R-isomer at C25. This excellent facial selec-
tivity has been demonstrated, e.g., for anilines as nucleophiles
before. It is due to the preferred conformation around the bond
at C24–C25 which leads to the efficient shielding of the si-face
by the two germinal methyl groups at C22 [4,5]. The NMR data
determined for both synthetic products were identical with those
of authentic samples of elansolid B1 (2) and elansolid B2 (3)
(copies of spectra, see Supporting Information File 1).
Conclusion
In conclusion, we describe an improved second generation syn-
thesis of the highly active antibiotic elansolid B1 (2). The
improvements are mainly associated with the preparation of the
triene unit at C10–C15 by utilizing the Stille and the
Suzuki–Miyaura cross-coupling reactions as well as the highly
versatile difunctionalized building block 14. In principal, the
synthesis sheds light on how such (Z,E,Z)-configured triene
units are ideally be constructed, clearly demonstrating that
enediynes are less preferred precursors for such structural ele-
ments. It has to be noted that there is precedence in the litera-
ture for the use of the Suzuki–Miyaura cross-coupling reaction
as key step to assemble differently configured trienes present in
polyketides [12-15].
Furthermore, we show how the intermediate p-methide quinone
can be exploited to also prepare elansolid B2 (3). The improved
synthesis allows more easily preparing analogues of the elan-
solids for further biological evaluation.
Experimental
General information:
1H NMR spectra were recorded at 400 MHz or 500 MHz, re-
spectively, and 13C NMR spectra were recorded at 100 MHz or
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Scheme 3: Total synthesis of elansolids B1 (2) and B2 (3).
125 MHz, respectively, with a Bruker Avance 400, DPX 400 or
DRX 500. Chemical shift values of NMR data are reported as
values in ppm relative to the (residual undeuterated) solvent
signal as internal standard. Multiplicities for 1H NMR signals
are described using the following abbreviations: s = singlet,
d = doublet, t = triplet, q = quartet, m = multiplet; where appro-
priate with the addition of b = broad. Mass spectra were ob-
tained with a type LCT (ESI) (Micromass) equipped with a
lockspray dual ion source in combination with a Waters
Alliance 2695 LC system, or with a type QTOF premier
(Micromass) spectrometer (ESI mode) in combination with a
Waters Acquity UPLC system equipped with a Waters BEH
C18 1.7 μm (SN 01473711315545) column (solvent A:
water + 0.1% (v/v) formic acid, solvent B: MeOH + 0.1% (v/v)
formic acid; flow rate = 0.4 mL/min; gradient (t [min]/solvent B
[%]): (0:5) (2.5:95) (6.5:95) (6.6:5) (8:5)). Ion mass signals
(m/z) are reported as values in atomic mass units. Optical rota-
tions were measured on a Perkin-Elmer polarimeter type 341 or
Beilstein J. Org. Chem. 2017, 13, 1280–1287.
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241 in a quartz glass cuvette at l = 589 nm (Na D-line). The
optical rotation is given in [° mL·g−1·dm−1] with c = 1 corre-
sponding to 10 mg mL−1. Preparative HPLC was operated at a
Merck Hitachi LaChrome HPLC (Pump L7150 or L7100, Inter-
face D-7000, Diode Array Detector L-7450), respectively, at a
Beckmann system Gold HPLC (Solvent Module 125, Detector
166). Solvents, columns, operating procedures and retention
times are given with the corresponding experimental and analyt-
ical data.
All reactions were performed under an argon atmosphere unless
otherwise stated. Glassware was dried by heating under vacuum
followed by flushing with argon gas prior to use. Dry solvents
were obtained after filtration through drying columns on a
M. Braun solvent purification system or purchased form com-
mercial providers. The synthesis of building blocks 9 [7] and 12
[9] was reported before.
Synthetic experiments
Synthesis of boronate 13
A flame dried round bottom flask equipped with a stirring bar
was charged with vinyl iodide 12 (10 mg, 16 µmol, 1.0 equiv)
and boronate 14 (10.68 mg, 24 µmol, 1.5 equiv) in DMF
(0.3 mL) and THF (0.1 mL). To this stirred solution
PdCl2(MeCN)2 (1.25 mg, 4.8 µmol, 0.3 equiv) was added at
room temperature and stirring was continued for 8 h. The vola-
tiles were removed in vacuo and the residue was purified by
silica gel chromatography to afford vinyl boronate 13 (8.5 mg,
12.3 µmol, 82%). Rf = 0.40 (PE/EtOAc 10:1, visualized using
an anisaldehyde stain or UV), [α]D20 = −34.5 (c 0.8, CH2Cl2);
1H NMR (400 MHz, CDCl3, CHCl3 = 7.26 ppm) δ 7.32 (d, J =
15.6 Hz, 1H), 7.25 (d, J = 11.4, 17.5 Hz, 1H), 6.09 (t, J = 11.1
Hz, 1H), 5.97 (dd, J = 7.1 Hz, 1H), 5.78 (d, J = 15.5 Hz, 1H),
5.61 (d, J = 17.4 Hz, 1H), 5.57 (t, J = 10.2 Hz, 1H), 4.63 (dd, J
= 6.4, 9.2 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 3.84–3.80 (m, 1H),
2.42–2.34 (m, 1H), 2.27–2.23 (m, 1H), 1.76 (s, 3H), 1.74–1.71
(m, 1H), 1.33 (t, J = 7.2 Hz, 3H), 1.28 (s, 12H), 0.97–0.93 (m,
21H), 0.59 (q, J = 8.0Hz, 12H); 13C NMR (100 MHz,
CDCl3 = 77.16 ppm) δ 167.6, 149.6, 143.8, 139.6, 137.4, 133.6,
130.6, 123.3, 115.4, 83.2, 72.5, 69.8, 60.1, 47.1, 32.6, 24.8,
24.7, 14.3, 12.6, 9.7, 7.0, 6.9, 5.2, 5.1; HRMS (ESI)
m/z: [M + Na]+ calculated for C35H65BO6Si2Na, 671.4310;
found, 671.4312.
Reduction of ketone 9 and formation of benzyl
alcohol
A solution of ketone 9 (466.2 mg, 0.79 mmol, 1.0 equiv) in
THF (3 mL) was added to a suspension of LiAlH4 (599.2 mg,
15.79 mmol, 20 equiv) in THF (12 mL) at −70 °C. After stir-
ring for 3 d at this temperature the reaction was terminated by
slow addition of a saturated potassium sodium tartrate solution.
The reaction mixture was vigorously stirred for 1 h at room
temperature. The layers were seperated and the aqueous phase
was extracted with ethyl acetate. The combined organic extracts
were dried over Na2SO4, filtered and concentrated under
reduced pressure. The resulting benzyl alcohol (371.7 mg,
0.63 mmol, 80%, d.r. = 3:1) was obtained after flash column
chromatography. Separation of diastereomers was achieved by
preparative HPLC (C18 ISIS-SP) (gradient H2O/MeOH 30:70
to 0:100 {0–80 min}, 15 mL/min, tR = 67.6 min). Rf = 0.6 (PE/
EtOAc 5:1, visualized using anisaldehyde stain or UV),
[α]D20 = +28.9 (c 0.82, CH2Cl2); 1H NMR (400 MHz, CDCl3,
CHCl3 = 7.26 ppm) δ 7.48 (d, J = 8.0 Hz, 2H), 7.42 (d, J = 7.9
Hz, 2H), 7.30 (d, J = 9.8 Hz, 2H), 7.19 (t, J = 7.5 Hz, 2H), 7.08
(t, J = 7.3 Hz, 1H), 6.94–6.89 (m, J = 6.8 Hz, 4H), 5.60 (s, 1H),
5.29 (dd, J = 2.9, 11.0 Hz, 1H), 4.47 (d, J = 10.8 Hz, 1H), 4.40
(d, J = 10.8 Hz, 1H), 4.27 (d, J = 11.1 Hz, 1H, OH), 3.83 (s,
3H), 2.87 (d, J = 10.7 Hz, 1H), 2.57 (br, 1H), 2.48 (d, J = 2.4
Hz, 1H), 2.33 (s, 2H), 2.20 (ddd, J = 3.5, 4.6, 11.4 Hz, 1H),
2.10 (d, J = 14.0 Hz, 1H), 2.02 (dd, J = 11.8, 12.0 Hz, 1H),
1.69 (s, 3H), 1.69 (d, J = 13.6 Hz, 1H), 1.40 (s, 3H), 1.32 (s,
3H), 1.29 (s, 3H), 0.29 (s, 6H); 13C NMR (100 MHz,
CDCl3 = 77.16 ppm) δ 158.9, 144.3, 139.7, 136.6, 133.8, 133.2,
131.8, 128.7, 128.3, 128.1, 124.7, 124.1, 123.7, 113.8, 86.7,
81.3, 73.9, 73.5, 64.9, 55.8, 55.3, 52.9, 46.6, 45.3, 38.0, 33.4,
31.1, 26.3, 24.2, 22.7, 21.3, −3.4, −3.3; HRMS (ESI)
m/z: [M + Na]+ calculated for C39H48O3SiNa, 615.3270; found,
615.3270.
Synthesis of phenol 15
To a solution of the benzyl alcohol described above (124.0 mg,
0.21 mmol, 1.0 equiv) in THF (0.75 mL) was added a solution
of TBAF (c = 1.0 M in THF, 0.84 mL, 4.0 equiv) and the mix-
ture was stirred for 15 min. Methanol (2.23 mL), KHCO3
(41.85 mg, 0.42 mmol, 2.0 equiv) and H2O2 (35% in H2O,
0.36 mL, 4.18 mmol, 20 equiv) were sequentially added and
stirring was continued overnight. Then, the reaction was termi-
nated by slow addition of a saturated, aqueous Na2S2O3 solu-
tion and the aqueous layer was extracted with ethyl acetate. The
combined organic extracts were dried over Na2SO4 filtered and
concentrated in vacuo. Purification by flash column chromatog-
raphy gave phenol 15 (96.0 mg, 0.20 mol, 99%) as a colorless
solid. Rf = 0.20 (PE/EtOAc 3:1, visualized using an anisalde-
hyde stain or UV), [α]D20 = +26.1 (c 0.7, CH2Cl2); 1H NMR
(400 MHz, CDCl3, CHCl3 = 7.26 ppm) δ 7.31–7.28 (m, 4H),
6.90 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.6 Hz, 2H), 5.59 (s, 1H),
5.25 (dd, J = 3.0, 10.9 Hz, 1H), 4.97 (s, 1H, OH), 4.47 (d, J =
10.8 Hz, 1H), 4.39 (d, J = 10.8 Hz, 1H), 4.22 (d, J = 10.9 Hz,
1H), 3.82 (s, 3H), 2.85 (dd, J = 1.8, 12.4 Hz, 1H), 2.60 (br, 1H),
2.45 (d, J = 2.5 Hz, 1H), 2.13 (ddd, J = 3.8, 4.4, 11.1Hz, 1H),
2.08 (d, J = 14.0 Hz, 1H), 2.00 (t, J = 11.8 Hz, 1H), 1.68 (s,
3H), 1.67 (d, J = 13.7 Hz, 1H), 1.38 (s, 3H), 1.30 (s, 3H), 1.28
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(s, 3H); 13C NMR (100 MHz, CDCl3 = 77.16 ppm) δ 158.9,
154.4, 135.5, 133.2, 131.8, 128.7, 126.6, 123.7, 115.2, 113.8,
86.8, 81.3, 73.9, 73.1, 64.9, 55.7, 55.3, 52.9, 46.7, 45.4, 38.0,
33.3, 31.1, 24.2, 22.7, 21.3; HRMS (ESI) m/z: [M + H]+ calcu-
lated for C30H37O4, 461.2692; found, 461.2693.
Synthesis of acetyl ester 16
A round bottom flask equipped with a magnetic stirring bar was
sequentially charged with alcohol 15 (89.6 mg, 0.195 mmol,
1.0 equiv), CH2Cl2 (2 mL), DMAP (23.82 mg, 0.196 mmol,
1.0 equiv), Et3N (0.204 mL, 1.46 mmol, 7.4 equiv) and Ac2O
(0.092 mL, 0.973 mmol, 4.0 equiv). After stirring at ambient
temperature for 2 d the reaction was terminated by addition of
H2O and extracted with Et2O several times. The combined
organic phases were dried over anhydrous Na2SO4, filtered,
concentrated in vacuo. The residue was purified by silica gel
column chromatography to give compound 16 (93 mg,
0.17 mmol, 88%). Rf = 0.5 (PE/EtOAc 3:1, visualized using an
anisaldehyde or UV), [α]D20 = +35.8 (c 0.5, CH2Cl2); 1H NMR
(400 MHz, CDCl3, CHCl3 = 7.26 ppm) δ 7.41 (d, J = 8.6 Hz,
2H), 7.27 (d, J = 9.0 Hz, 2H), 7.11 (d, J = 8.6 Hz, 2H), 6.89 (d,
J = 8.7 Hz, 2H), 6.01 (d, J = 3.2 Hz, 1H), 5.54 (s, 1H), 4.44 (d,
J = 10.8 Hz, 1H), 4.37 (d, J = 10.8 Hz, 1H), 3.82 (s, 3H), 2.84
(dd, J = 1.8, 12.3 Hz, 1H), 2.65 (br, 1H), 2.32 (s, 3H), 2.24 (d, J
= 2.6 Hz, 1H), 2.14 (s, 3H), 2.10–2.06 (m, 1H), 2.03–2.00 (m,
2H), 1.73 (s, 3H), 1.60 (d, J = 14.0 Hz, 1H), 1.28 (s, 3H),
1.24 (s ,  3H),  1 .11 (s ,  3H);  1 3C NMR (100 MHz,
CDCl3 = 77.16 ppm) δ 170.3, 169.3, 158.9, 149.9, 137.0, 134.5,
131.7, 128.7, 126.9, 122.7, 121.5, 113.8, 85.4, 81.0, 74.9, 71.0,
64.9, 55.7, 55.3, 53.5, 46.1, 45.8, 37.9, 34.6, 29.9, 23.8, 22.8,
21.6, 21.2, 21.1; HRMS (ESI) m/z: [M + Na]+ calculated for
C34H40O6Na, 567.2723; found, 567.2728.
Synthesis of vinyl iodide 17
To a stirred solution of compound of 16 (88 mg, 0.162 mmol,
1.0 equiv) in acetone (4 mL) was added AgNO3 (8.3 mg,
0.05 mmol, 0.3 equiv) and N-iodosuccinimide (40.0 mg,
0.18 mmol, 1.1 equiv) at ambient temperature. The resulting
mixture was stirred for 1.5 h and concentrated in vacuo. The
residue was purified by silica gel column chromatography to
give the corresponding alkynyl iodide (91.0 mg, 0.136 mmol,
84%). This product (81.9 mg, 0.12 mmol, 1.0 equiv) was dis-
solved in a mixture of THF (1.1 mL) and iPrOH (1.1 mL). Et3N
(0.026 mL, 0.183 mmol, 1.5 equiv) and 2-nitrobenzenesulfonyl
hydrazide (34.5 mg, 0.159 mmol, 1.3 equiv) were sequentially
added. After stirring for 20 h, Et3N (0.026 mL, 0.183 mmol,
1.5 equiv) and 2-nitrobenzenesulfonyl hydrazide (17.25 mg,
0.079 mmol, 0.7 equiv) were added and the reaction mixture
was stirred for additional 5 h. The volatiles were then removed
in vacuo at ambient temperature. The residue was purified by
silica gel column chromatography to give vinyl iodide 17
(62.0 mg, 0.092 mmol, 77%). Rf = 0.60 (PE/EtOAc 3:1, visual-
ized using an anisaldehyde stain or UV), [α]D20 = +14.1 (c 0.95,
CH2Cl2); 1H NMR (400 MHz, CDCl3, CHCl3 = 7.26 ppm) δ
7.28 (d, J = 8.6 Hz, 2H), 7.17 (d, J = 8.6 Hz, 2H), 7.11 (d, J =
8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.43 (dd, J = 7.8, 9.4 Hz,
1H), 6.29 (d, J = 7.5 Hz, 1H), 6.03 (d, J = 2.5 Hz, 1H), 5.56 (s,
1H), 4.45 (d, J = 10.8 Hz, 1H), 4.38 (d, J = 10.8 Hz, 1H), 3.82
(s, 3H), 2.89–2.83 (m, 2H), 2.37 (ddd, J = 2.9, 3.7, 10.9 Hz,
1H), 2.31 (s, 3H), 2.15 (s, 3H), 2.07 (d, J = 14.0 Hz, 1H), 1.79
(t, J = 11.8 Hz, 1H), 1.64 (s, 3H), 1.59 (d, J = 14.0 Hz, 1H),
1.30 (s, 3H), 1.24 (s, 3H), 1.09 (s, 3H); 13C NMR (100 MHz,
CDCl3 = 77.16 ppm) δ 169.9, 169.3, 158.9, 149.6, 141.9, 136.1,
135.2, 131.7, 128.7, 126.7, 123.7, 121.9, 113.8, 80.9, 80.1, 75.5,
64.9, 55.9, 55.3, 53.4, 46.6, 46.1, 46.0, 38.3, 30.1, 23.5, 22.7,
22.2, 21.3, 21.2; HRMS (ESI) m/z: [M + Na]+ calculated for
C34H41O6INa, 695.1846; found, 695.1837.
Synthesis of vinyl iodide 18
DDQ (56.5 mg, 0.25 mmol, 3.0 equiv) was added to a stirred
solution of 17 (55.8 mg, 0.083 mmol, 1.0 equiv) in CH2Cl2
(4.5 mL)/pH 7.0 phosphate buffer (0.45 mL) at 0 °C. After stir-
ring for 1.5 h, the reaction mixture was terminated by addition
of a saturated, aqueous NaHCO3 solution. The aqueous solu-
tion was extracted with Et2O. The combined, organic phases
were dried over anhydrous Na2SO4, filtered, concentrated in
vacuo and the crude product was purified by silica gel column
chromatography to furnish the title vinyl iodide 18 (40.0 mg,
0.072 mol, 87%). Rf = 0.25 (PE/EtOAc 3:1, visualized using an
anisaldehyde or UV), [α]D20 = +36.7 (c 0.86, CH2Cl2);
1H NMR (400 MHz, CDCl3, CHCl3 = 7.26 ppm) δ 7.17 (d, J =
8.6 Hz, 2H), 7.11 (d, J = 8.6 Hz, 2H), 6.40 (dd, J = 7.6, 9.6 Hz,
1H), 6.28 (d, J = 7.6 Hz, 1H), 6.03 (d, J = 2.3 Hz, 1H), 5.51 (s,
1H), 2.84 (dd, J = 4.1, 9.6 Hz, 1H), 2.70 (d, J = 12.7 Hz, 1H),
2.34 (ddd, J = 2.8, 4.0, 11.3 Hz, 1H), 2.31 (s, 3H), 2.15 (s, 3H),
1.84 (d, J = 14.2 Hz, 1H), 1.77 (d, J = 14.2 Hz, 1H), 1.74 (t, J
= 11.9 Hz, 1H), 1.65 (s, 3H), 1.30 (s, 3H), 1.19 (s, 3H), 1.07 (s,
3H); 13C NMR (100 MHz, CDCl3 = 77.16 ppm) δ 169.9, 169.3,
149.6, 141.8, 136.1, 135.7, 126.7, 122.4, 121.9, 80.1, 76.2, 75.4,
60.1, 54.8, 46.4, 46.3, 45.9, 38.1, 30.2, 26.4, 23.9, 22.2, 21.2,
21.1; HRMS (ESI) m/z: [M + Na]+ calculated for C26H33O5INa,
575.1270; found, 575.1272.
Synthesis of triene 19
To a stirred solution of vinyl iodide 18 (21 mg, 40.2 µmol,
1.0 equiv) and boronate 13 (39.12 mg, 60.0 µmol, 1.5 equiv) in
THF (5 mL) and H2O (1.25 mL) were sequentially added thal-
lium(I) carbonate (33.92 mg, 72.0 µmol, 1.8 equiv) and
Pd(PPh3)4 (13.93 mg, 12.0 µmol, 0.3 equiv) at room tempera-
ture. The reaction mixture was stirred for 4 h and then H2O was
added. The aqueous solution was extracted with Et2O. The
combined, organic phases were dried over anhydrous Na2SO4,
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filtered, concentrated in vacuo and the crude product was puri-
fied by silica gel column chromatography to furnish the title
triene 19 (29.3 mg, 31.0 µmol, 77%). Rf = 0.4 (PE/EtOAc 2:1,
visualized using an anisaldehyde or UV), [α]D20 = +77.2
(c  0.53, CH2Cl2);  1H NMR (400 MHz, acetone-d6 ,
acetone-d5 = 2.05 ppm) δ 7.32 (d, J = 15.7 Hz, 1H, H3), 7.19
(d, J = 8.5 Hz, 2H, H27), 7.00 (d, J = 8.5 Hz, 2H, H28), 6.64
(dd, J = 11.7, 14.1 Hz, 1H, H12), 6.17 (dd, J = 10.9, 11.2 Hz,
1H, H14), 6.11–6.04 (m, 3H, H5, H11, H13), 6.01 (d, J = 2.6
Hz, 1H, H25), 5.83 (d, J = 15.7 Hz, 1H, H2), 5.78 (d, J = 10.4,
10.7 Hz, 1H, H15), 5.55 (s,1H, H18), 5.48 (t, J = 10.1 Hz, 1H,
H10), 4.71 (dd, J = 6.6, 9.2 Hz, 1H, H9), 4.14 (q, J = 7.1 Hz,
2H, H1’), 4.05–4.00 (m, 1H, H7), 2.87–2.88 (m, 1H, H16), 2.74
(d, J = 12.6 Hz, 1H, H19), 2.49 (t, J = 6.9 Hz, 2H, H6), 2.39
(ddd, J = 3.3, 3.5, 11.4 Hz, 1H, H24), 2.27 (s, 3H, H12’), 2.12
(s, 3H, H10’), 1.93 (dd, J = 11.8, 11.9 Hz, 1H, H23), 1.89 (s,
3H, H3’), 1.84 (d, J = 13.6 Hz, 1H, H21b), 1.83–1.80 (m, 1H,
H8), 1.73 (d, J = 13.9 Hz, 1H, H21a), 1.45 (s, 3H, H5’), 1.30 (s,
3H, H6’), 1.23 (t, J = 7.1 Hz, 3H, H2’), 1.14 (s, 3H, H8’), 1.08
(d, J = 6.8 Hz, 3H, H4’), 1.07 (s, 3H, H7’), 1.04–0.99 (m, 18H,
H14’, H16’), 0.70–0.58 (m, 12H, H13’, H15’); 13C NMR
(400 MHz, acetone-d6 = 29.8 and 206.3 ppm) δ 169.4 (C9’),
168.7 (C11’), 166.4 (C1), 149.8 (C29), 148.8 (C3), 139.3 (C5),
137.1 (C26), 134.9 (C17), 134.5 (C15), 133.8 (C4), 133.2
(C10), 131.6 (C13), 129.4 (C11), 127.1 (C12), 126.5 (C27),
125.6 (C14), 122.7 (C18),121.3 (C28), 115.9 (C2), 75.0 (C25) ,
74.8 (C20), 72.9 (C7), 70.1 (C9), 60.2 (C21), 59.6 (C1’), 55.1
(C19), 47.4 (C8), 46.6 (C24), 44.7 (C23), 40.8 (C16), 37.5
(C22), 32.6 (C6), 29.8 (C7’), 25.7 (C8’), 23.6 (C6’), 20.6 (C5’),
20.3 (C12’), 20.1 (C10’), 13.7 (C2’), 11.9 (C3’), 9.5 (C4’), 6.5
(C14’), 6.3 (C16’), 4.9 (C13’,15’); HRMS (ESI) m/z: [M + Na]+
calculated for C55H86O9Si2Na, 969.5708; found, 969.5707.
Synthesis of elansolid B1 (2)
Polyene 19 (2.65 mg, 2.79 µmol, 1.0 equiv) was dissolved in
THF (0.5 mL) and cooled to 0 °C. A solution of hydrogen fluo-
ride pyridine complex (0.5 mL) prepared by mixing hydrogen
fluoride pyridine (2 mL; hydrogen fluoride ≈70 %) with pyri-
dine (5.6 mL) in THF (9.8 mL) at 0 °C. The reaction mixture
was stirred for 1 h at this temperature and the reaction was
terminated by addition of a saturated bicarbonate solution. The
aqueous solution was extracted with Et2O for three times. The
combined organic phases were dried over Na2SO4, filtered and
concentrated under reduced pressure to afford the correspond-
ing diol suitably pure for directly being employed in the next
step. An aqueous solution of LiOH (1 M, 0.3 mL, 107 equiv)
was added to crude diol in iPrOH (0.3 mL) and THF (0.3 mL)
at room temperature. After stirring for 5 h, the reaction was
terminated by slowly adding HCl (1 N, 0.24 mL), phosphate
buffer (pH 7, 0.1 mL) and MeOH (0.3 mL). The crude mixture
was directly subjected to HPLC (C18 ISIS-SP) (MeOH: H2O/
50 mM NH4OAc 70:30 to MeOH:H2O/50 mM NH4OAc 100:0
{0–70 min}, 3.0 mL/min) to give elansolid B1 (2) (0.88 mg,
1.45 µmol, 52% over two steps, tR = 47.8 min). [α]D20 = +176.0
(c  0 .05,  MeOH);  1H NMR (500 MHz, acetone-d6 ;
acetone-d5 = 2.05 ppm) δ 7.35 (d, J = 15.6 Hz, 1H, H3), 7.14
(d, J = 8.3 Hz, 2H, H27), 6.75 (d, J = 8.5 Hz, 2H, H28), 6.57
(dd, J = 12.2, 13.6 Hz, 1H, H12), 6.17 (t, J = 7.23 Hz, 1H, H5),
6.09–6.02 (m, 2H, H13, H14), 5.99 (dd, J = 10.8, 11.0 Hz, 1H,
H11), 5.84 (d, J = 15.7 Hz, 1H, H2), 5.70 (t, J = 10.5 Hz, 1H,
H15), 5.55 (dd, J = 9.5, 10.9 Hz, 1H, H10), 5.52 (s, 1H, H18),
5.18 (d, J = 2.5 Hz, 1H, H25), 4.94 (ddd, J = 0.9, 3.6, 8.6 Hz,
1H, H9), 3.87–3.84 (m, 1H, H7), 2.92 (dd, J = 4.0, 10.8 Hz, 1H,
H16), 2.69 (d, J = 2.6 Hz, 1H, H19), 2.59 (ddd, J = 4.2, 6.8,
15.3 Hz, 1H, H6a), 2.51–2.47 (m, 1H, H6b), 2.22–2.18 (m, 1H,
H24), 1.99–1.95 (m, 1H, H23), 1.88 (s, 3H, H1’), 1.83–1.80 (m,
1H, H8), 1.83 (d, J = 13.8 Hz, 1H, H21a), 1.73 (d, J = 13.8 Hz,
1H, H21b), 1.44 (dd, J = 1.4, 2.2 Hz, 3H, H3’), 1.30 (s, 3H,
H5’), 1.29 (s, 3H, H6’), 1.14 (s, 3H, H4’), 1.03 (d, J = 7.0 Hz,
3H, H2’); 13C NMR (125 MHz, acetone-d6 = 29.8 and 206.3
ppm) δ 167.5 (C1), 155.7 (C29), 149.4 (C3), 138.9 (C5), 135.2
(C26, C17), 134.8 (C15), 133.8 (C4), 132.9 (C10), 130.9 (C13),
129.3 (C11), 127.5 (C12), 127.0 (C27), 126.5 (C14), 122.5
(C18), 115.9 (C2), 114.5 (C28), 74.9 (C20), 73.0 (C7), 72.2
(C25), 68.5 (C9), 60.5 (C21), 55.1 (C19), 48.4 (C24), 44.5
(C23), 44.0 (C8), 40.4 (C16), 37.7 (C22), 34.1 (C6), 30.9 (C5’),
25.7 (C4’), 23.8 (C6’), 20.6 (C3’), 11.8 (C1’), 10.7 (C2’);
HRMS (ESI) m/z: [M + Na]+ calculated for C37H50O7Na,
629.3454; found, 629.3463.
Synthesis of elansolid B2 (3)
In aqueous solution of LiOH (1 M, 0.3 mL, 107 equiv) was
added to the crude diol (3.1 µmol) described for the synthesis of
elansolid B1 (2) in MeOH (0.3 mL) and THF (0.3 mL) at room
temperature. After stirring for 5 h, the reaction was terminated
by slowly adding HCl (1 N, 0.24 mL), phosphate buffer (pH 7,
0.1 mL) and MeOH (0.3 mL). The crude mixture was directly
subjected to HPLC (C18 ISIS-SP) (MeOH: H2O/50 mM
NH4OAc 70:30 to MeOH:H2O/50 mM NH4OAc 100:0
{0–70 min}, 3.0 mL/min) to give elansolid B2 (3) (1.2 mg,
1.93 µmol, 63% over two steps, tR = 63.4 min). [α]D20 = +262.1
(c  0.087, MeOH); 1H NMR (400 MHz, acetone-d6 ;
acetone-d5 = 2.05 ppm) δ 7.35 (d, J = 15.7 Hz, 1H, H3), 7.07
(d, J = 8.4 Hz, 2H, H27), 6.77 (d, J = 8.5 Hz, 2H, H28), 6.63
(dd, J = 11.5, 14.6 Hz, 1H, H12), 6.34 (dd, J = 11.5, 14.6 Hz,
1H, H13), 6.18 (t, J = 7.2 Hz, 1H, H5), 6.13 (t, J = 11.2 Hz,
1H, H11), 6.02 (t, J = 11.2 Hz, 1H, H14), 5.82 (d, J = 15.7 Hz,
1H, H2), 5.68 (t, J = 10.8 Hz, 1H, H15), 5.57 (dd, J = 9.7, 10.1
Hz, 1H, H10), 5.48 (s, 1H, H18), 4.99 (ddd, J = 0.9, 3.5, 8.6
Hz, 1H, H9), 4.66 (d, J = 2.4 Hz, 1H, H25), 3.88–3.84 (m, 1H,
H7), 3.12 (s, 3H, H7’), 2.90 (dd, J = 3.3, 10.6 Hz, 1H, H16),
2.64–2.62 (m, 1H, 19H), 2.60–2.58 (m, 1H, H6a), 2.52–2.44
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(m, 1H, H6b), 2.01–1.97 (m, 1H, H24), 1.95–1.91 (m, 1H,
H23), 1.89 (s, 3H, H1’), 1.85–1.82 (m, 1H, H8), 1.82 (d, J =
13.5 Hz, 1H, H21a), 1.72 (d, J = 13.8 Hz, 1H, H21b), 1.45 (dd,
J = 1.3, 2.1 Hz, 3H, H3’), 1.29 (s, 3H, H5’), 1.21 (s, 3H, H6’),
1.12 (s, 3H, H4’), 1.03 (d, J = 7.0 Hz, 3H, H2’); 13C NMR
(100 MHz, acetone-d6 = 29.8 and 206.3 ppm) δ 167.3 (C1),
156.2 (C29), 149.4 (C3), 139.0 (C5), 135.5 (C15), 135.3 (C17),
133.8 (C4), 132.5 (C10), 131.6 (C13), 131.0 (C26), 129.4
(C11), 128.3 (C27), 126.8 (C12), 124.3 (C14), 122.5 (C18),
115.7 (C2), 114.7 (C28), 82.9 (C25), 74.8 (C20), 73.0 (C7),
68.5 (C9), 60.4 (C21), 55.6 (C7’), 55.2 (C19), 48.8 (C24), 44.8
(C23), 44.0 (C8), 40.3 (C16), 37.6 (C22), 34.2 (C6), 30.4 (C6’),
25.7 (C4’), 23.7 (C5’), 20.9 (C3’), 11.8 (C1’), 10.8 (C2’);
HRMS (ESI) m/z: [M + Na]+ calculated for C38H52O7Na,
643.3611; found, 643.3611.
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